Search Results for "Humulin R Pharmacokinetics"
Original Source: Pharmacokinetic (PK),, Pharmacodynamic (PD) of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin R® With and Without rHuPH20
The purpose of the study was to compare the pharmacokinetics and pharmacodynamics of Humalog or Humulin R insulin when administered as a single 20-U subcutaneous (SC) injection with or without coadministration of rHuPH20. The study hypothesizes that the time required to reach maximum insulin concentration (Tmax) when insulin is administered with rHuPH20 will be comparable or shorter than the time required without rHuPH20.
Matching Channels
Macitentan (Opsumit®) is a novel dual endothelin receptor antagonist (ERA) that resulted from a tailored drug discovery process with the target to develop an ERA optimized for efficacy and safet...
Top 50 Biopharma Products 2011
Ronald A. Rader, president of the Biotechnology Information Institute provided Contract Pharma a list of the Top 57 Biopharma Products by 2011 revenues (in millions). Mr. Rader subscribes to the sam...
The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...
Matching News
Humanized FcRn Mice: promising tools for evaluating the pharmacokinetics of monoclonal antibodies
Ray Lambert discusses humanized FcRn mice and their role in evaluating the pharmacokinetics of mAbs. Due to their extraordinary specificity and pharmacokinetic (PK) behavior, human immunoglobulin gam...
Kinetigen to Showcase Pharmacokinetics Expertise at ASCPT Annual Meeting and Exhibition
Kinetigen, Inc., a specialty pharmaceutical consulting firm with global reach, will be exhibiting and sharing its in-depth knowledge of how to use Pharmacokinetics (PK) more effic...
Type: Original PaperThis study investigated the effects of genetic polymorphisms in organic cation transporter (OCT) genes, such as OCT1-3, OCTN1, MATE1, and MATE2-K, on metformin pharmacokinetics. Of...
Type: Original PaperWhile therapeutic proteins (TP), particularly recombinant human proteins and fully human monoclonal antibodies, are designed to have a low immunogenic potential in humans, a clinic...
Insulet, Eli Lilly collaborate to develop new version of OmniPod insulin pump
Insulet Corporation and Eli Lilly and Company have entered into a collaboration under which Insulet will develop a new version of the OmniPod insulin pump designed to deliver Humulin R U-500 insulin.
Lilly Launches Latest Innovation In Insulin Delivery
HumaPen® SAVVIO TM Design Inspired by People Living with Diabetes to Meet their Individual Needs Lilly announced the launch of the new HumaPen® SAVVIOTM this week at the Diabetes UK Professional Con...
Population pharmacokinetics of lamotrigine in Chinese children with epilepsy
Sorafenib in advanced melanoma: a critical role for pharmacokinetics?
Matching PubMed Articles
Letter to the Editor: Pharmacokinetics of Non-Intravenous Formulations of Fentanyl.
Therapeutic hypothermia can influence the pharmacokinetics and pharmacodynamics of drugs, the discipline which is called thermopharmacology. We studied the effect of therapeutic hypothermia on the pha...
Etanercept pharmacokinetics in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriasis were assessed separately with distinct models using population pharmacokinetics metho...
Translational pharmacokinetics: challenges of an emerging approach to drug development in stroke.
Introduction: There is increasing recognition of the importance of translational pharmacokinetics in stroke research, lack of which has been cited as one of the main contributing factors to failure of...
